The continuous growth of the healthcare sector is followed by a corresponding demand to reduce costs and to improve the quality of its management processes. One way to meet these requirements is to leverage on a better management and traceability of medicines and medical devices through ICT, not only at the hospital but also at the patient's home. The project "LIFEMED -Integrated Logistic of Medicines and Medical Devices", aims, indeed, at the realization of an innovative digital model for medicines and medical devices logistic management. In particular, for the management and the traceability of medicines and medical devices at home, the solution will be characterized by a telemedicine platform together with a traceability platform based on RFId and barcode labels and readers. The telemedicine and traceability platforms will allow for a better monitoring of respectively the patient's correct medicine administration and the medicines and medical devices logistic, as demonstrated by the example of the peritoneal dialysis, a domiciliary treatment addressed in the project. Despite all the advantages, attention must be paid during the platform design in considering crucial factors like digital illiteracy of older people and the privacy, legal and ethical issues.
Rare cancers represent about 20% of the total number of cancers diagnosed in Europe, with an occurrence of less than 6 per 100.000 individuals annually. Despite the impact of each rare disease is limited, rare diseases collectively are a true challenge for public health authorities. In particular, rare cancers face specific challenges that include late/incorrect diagnosis and lack of clinical expertise. In this context, rare cancers networks play a central role in linking national designed centres of expertise far from each other. These collaborations among clinical centres aim to improve the care quality of rare cancers in terms of patients' survival and of life quality. Moreover, the presence of a national collaborative network should induce a reduction of health migration and social costs. To foster these networks, it is important to use ICT solutions not only to support network collaborative processes, but also to monitor the overall collaboration process and to assess the related system impact. This paper describes the project "Italian Rare Cancer Network -Process Monitoring and System Impact Assessment" that aims to strengthen the collaborative Italian network Rete Tumori Rari (RTR) developing its quality system through an information system. The project results can be used as input for the definition of the organizational model and of the information system of the new Italian network of rare tumours (Rete Nazionale Tumori Rari) and to strengthen Italy
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.